OpEds | Action For Trade
17445
page-template,page-template-full_width,page-template-full_width-php,page,page-id-17445,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-child-theme-ver-,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

OpEds

NAFTA Needs Strong IP Protections for America’s Creators and Innovators

Morning Consult, April 11, 2018

READ MORE

Ottawa blocking access to innovative drugs, writes pharmaceutical policy researcher Nigel Rawson

The Spectator, January 19, 2018

READ MORE

When Trade Talks Can Cure Disease

Investor’s Business Daily, January 19, 2018

READ MORE

NAFTA 2.0 needs to protect American business patents

The Hill, January 18, 2018

READ MORE

Protect American ideas through trade

The Hill, January 11, 2018

READ MORE

OPINION: American bureaucrats think our progressive agenda will derail NAFTA

The Toronto Sun, December 23, 2017

READ MORE

Cheaper isn’t always better, and prescription drugs are no exception

The Hill Times, December 14, 2017

READ MORE

As Trump Renegotiates NAFTA, Intellectual Property Rights Should Top the Agenda

The Daily Signal, October 17, 2017

READ MORE

A better deal with NAFTA 2.0

Washington Times, October 15, 2017

READ MORE

New NAFTA must protect American innovation and creativity — not punish it

The Hill, October 11, 2017

READ MORE

Overbroad Safe Harbors—A Threat to a Healthy Internet

Bloomberg BNA, August 30, 2017

READ MORE